Cargando…

N-Acetylcysteine Compared to Metformin, Improves The Expression Profile of Growth Differentiation Factor-9 and Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients with Polycystic Ovarian Syndrome

BACKGROUND: Paracrine disruption of growth factors in women with polycystic ovarian syndrome (PCOS) results in production of low quality oocyte, especially following ovulation induction. The aim of this study was to investigate the effects of metformin (MET), N-acetylcysteine (NAC) and their combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheraghi, Ebrahim, Soleimani Mehranjani, Malek, Shariatzadeh, Seyed Mohammad Ali, Nasr Esfahani, Mohammad Hossein, Alani, Behrang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641458/
https://www.ncbi.nlm.nih.gov/pubmed/29043702
http://dx.doi.org/10.22074/ijfs.2018.5142
_version_ 1783271229296214016
author Cheraghi, Ebrahim
Soleimani Mehranjani, Malek
Shariatzadeh, Seyed Mohammad Ali
Nasr Esfahani, Mohammad Hossein
Alani, Behrang
author_facet Cheraghi, Ebrahim
Soleimani Mehranjani, Malek
Shariatzadeh, Seyed Mohammad Ali
Nasr Esfahani, Mohammad Hossein
Alani, Behrang
author_sort Cheraghi, Ebrahim
collection PubMed
description BACKGROUND: Paracrine disruption of growth factors in women with polycystic ovarian syndrome (PCOS) results in production of low quality oocyte, especially following ovulation induction. The aim of this study was to investigate the effects of metformin (MET), N-acetylcysteine (NAC) and their combination on the hormonal levels and expres- sion profile of GDF-9, BMP-15 and c-kit, as hallmarks of oocyte quality, in PCOS patients. MATERIALS AND METHODS: This prospective randomized, double-blind, placebo controlled trial aims to study the effects of MET, NAC and their combination (MET+NAC) on expression of GDF-9, BMP-15 and c-kit mRNA in oocytes [10 at the germinal vesicle (GV) stage, 10 at the MI stage, and 10 at the MII stage from per group] derived following ovulation induction in PCOS. Treatment was carried out for six weeks, starting on the third day of previous cycle until oocyte aspiration. The expression of GDF9, BMP15 and c-kit were determined by quantitative real time polymerase chain reaction (RT-qPCR) and western blot analysis. Data were analyzed with one-way ANOVA. RESULTS: The follicular fluid (FF) level of c-kit protein significantly decreased in the NAC group compared to the other groups. Significant correlations were observed between the FF soluble c-kit protein with FF volume, androstenedione and estradiol. The GDF-9 expression in unfertilized mature oocytes were significantly higher in the NAC group com- pared to the other groups (P<0.001). Similar difference was not observed between the MET, NAC+MET and control groups. The c-kit expression in unfertilized mature oocytes were significantly lower in the NAC group compared to the other groups (P<0.001). Similar difference was not observed between the MET, NAC+MET and control groups (Registration number: IRCT201204159476N1). CONCLUSION: We concluded that NAC can improve the quality of oocytes in PCOS.
format Online
Article
Text
id pubmed-5641458
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Royan Institute
record_format MEDLINE/PubMed
spelling pubmed-56414582018-01-01 N-Acetylcysteine Compared to Metformin, Improves The Expression Profile of Growth Differentiation Factor-9 and Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients with Polycystic Ovarian Syndrome Cheraghi, Ebrahim Soleimani Mehranjani, Malek Shariatzadeh, Seyed Mohammad Ali Nasr Esfahani, Mohammad Hossein Alani, Behrang Int J Fertil Steril Original Article BACKGROUND: Paracrine disruption of growth factors in women with polycystic ovarian syndrome (PCOS) results in production of low quality oocyte, especially following ovulation induction. The aim of this study was to investigate the effects of metformin (MET), N-acetylcysteine (NAC) and their combination on the hormonal levels and expres- sion profile of GDF-9, BMP-15 and c-kit, as hallmarks of oocyte quality, in PCOS patients. MATERIALS AND METHODS: This prospective randomized, double-blind, placebo controlled trial aims to study the effects of MET, NAC and their combination (MET+NAC) on expression of GDF-9, BMP-15 and c-kit mRNA in oocytes [10 at the germinal vesicle (GV) stage, 10 at the MI stage, and 10 at the MII stage from per group] derived following ovulation induction in PCOS. Treatment was carried out for six weeks, starting on the third day of previous cycle until oocyte aspiration. The expression of GDF9, BMP15 and c-kit were determined by quantitative real time polymerase chain reaction (RT-qPCR) and western blot analysis. Data were analyzed with one-way ANOVA. RESULTS: The follicular fluid (FF) level of c-kit protein significantly decreased in the NAC group compared to the other groups. Significant correlations were observed between the FF soluble c-kit protein with FF volume, androstenedione and estradiol. The GDF-9 expression in unfertilized mature oocytes were significantly higher in the NAC group com- pared to the other groups (P<0.001). Similar difference was not observed between the MET, NAC+MET and control groups. The c-kit expression in unfertilized mature oocytes were significantly lower in the NAC group compared to the other groups (P<0.001). Similar difference was not observed between the MET, NAC+MET and control groups (Registration number: IRCT201204159476N1). CONCLUSION: We concluded that NAC can improve the quality of oocytes in PCOS. Royan Institute 2018 2017-10-14 /pmc/articles/PMC5641458/ /pubmed/29043702 http://dx.doi.org/10.22074/ijfs.2018.5142 Text en Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Cheraghi, Ebrahim
Soleimani Mehranjani, Malek
Shariatzadeh, Seyed Mohammad Ali
Nasr Esfahani, Mohammad Hossein
Alani, Behrang
N-Acetylcysteine Compared to Metformin, Improves The Expression Profile of Growth Differentiation Factor-9 and Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients with Polycystic Ovarian Syndrome
title N-Acetylcysteine Compared to Metformin, Improves The Expression Profile of Growth Differentiation Factor-9 and Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients with Polycystic Ovarian Syndrome
title_full N-Acetylcysteine Compared to Metformin, Improves The Expression Profile of Growth Differentiation Factor-9 and Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients with Polycystic Ovarian Syndrome
title_fullStr N-Acetylcysteine Compared to Metformin, Improves The Expression Profile of Growth Differentiation Factor-9 and Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients with Polycystic Ovarian Syndrome
title_full_unstemmed N-Acetylcysteine Compared to Metformin, Improves The Expression Profile of Growth Differentiation Factor-9 and Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients with Polycystic Ovarian Syndrome
title_short N-Acetylcysteine Compared to Metformin, Improves The Expression Profile of Growth Differentiation Factor-9 and Receptor Tyrosine Kinase c-Kit in The Oocytes of Patients with Polycystic Ovarian Syndrome
title_sort n-acetylcysteine compared to metformin, improves the expression profile of growth differentiation factor-9 and receptor tyrosine kinase c-kit in the oocytes of patients with polycystic ovarian syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641458/
https://www.ncbi.nlm.nih.gov/pubmed/29043702
http://dx.doi.org/10.22074/ijfs.2018.5142
work_keys_str_mv AT cheraghiebrahim nacetylcysteinecomparedtometforminimprovestheexpressionprofileofgrowthdifferentiationfactor9andreceptortyrosinekinaseckitintheoocytesofpatientswithpolycysticovariansyndrome
AT soleimanimehranjanimalek nacetylcysteinecomparedtometforminimprovestheexpressionprofileofgrowthdifferentiationfactor9andreceptortyrosinekinaseckitintheoocytesofpatientswithpolycysticovariansyndrome
AT shariatzadehseyedmohammadali nacetylcysteinecomparedtometforminimprovestheexpressionprofileofgrowthdifferentiationfactor9andreceptortyrosinekinaseckitintheoocytesofpatientswithpolycysticovariansyndrome
AT nasresfahanimohammadhossein nacetylcysteinecomparedtometforminimprovestheexpressionprofileofgrowthdifferentiationfactor9andreceptortyrosinekinaseckitintheoocytesofpatientswithpolycysticovariansyndrome
AT alanibehrang nacetylcysteinecomparedtometforminimprovestheexpressionprofileofgrowthdifferentiationfactor9andreceptortyrosinekinaseckitintheoocytesofpatientswithpolycysticovariansyndrome